The market for Opioid-Induced Constipation (OIC) is expected to grow at a CAGR of nearly 4.5% between 2022 and 2027. Long-term opioid use can impair immune system function, complicating the progression of COVID-19 disease. Potential suppression of parts of the immune response in various stages of COVID-19 may be important in prevention, clinical support, and therapeutic use of medications. Furthermore, according to the World Health Organization’s August 2021 update, during the COVID-19 pandemic, there is a significant increase in drug overdose deaths reported in the United States, primarily due to rapid increases in overdose deaths involving synthetic opioids. As a result of such incidents, the federal government has taken steps to ensure that opioid drugs are used responsibly and that any side effects are minimised.
Healthcare organisations are now operating in a volatile environment, undergoing seismic shifts as a result of the introduction of novel medical treatments and increased internet usage. Astute patients have become more cautious as a result of this, as well as unparalleled online access to astounding amounts of information. As a result, there is an increased demand for smart, affordable, and tailored healthcare services. The COVID-19 pandemic has also increased demand for healthcare and related products and services, bolstering the overall performance of the healthcare industry.
For More Insights, Download Sample Copy of this Report: https://healthcaremarketreports.com/sample-request/opioid-induced-constipation-market/2698/
Global Opioid-Induced Constipation Market: Top Key Players
C.B. Fleet
Valeant Pharmaceuticals International
Daiichi Sankyo
Pfizer
Bayer
Daewoong
Ironwood Pharmaceuticals
Boehringer Ingelheim
Abbott
Theravance
Nektar Therapeutics
Cosmo Pharmaceuticals
Synergy Pharmaceuticals
Merck
AstraZeneca
Takeda Pharmaceutical
Shionogi
SLA Pharma
Sucampo
Progenics Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Mundipharma
Global Opioid-Induced Constipation Market: By Types
Oral
Parenteral
Global Opioid-Induced Constipation Market: By Applications
Drugstore
Hospital
Others
Geographically, the detailed analysis of consumption, revenue, and market share and growth rate of the following regions:
United States, Canada, Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia, Brazil, Mexico, Argentina, Columbia, Chile, Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of the World. Our specialised reports provide information that is tailored to the specific needs of all key stakeholders. Our reports include market evaluations that give our clients useful information about market size, current competition, and other factors.
Buy Now this Premium Report to Grow your Business: https://healthcaremarketreports.com/purchase/opioid-induced-constipation-market/2698/?license=single
FAQs:
• What is the driving factor for the growth of the Opioid-Induced Constipation?
• How will the COVID-19 pandemic impact the demand and consumption of the Opioid-Induced Constipation?
• What is the major application area of the Opioid-Induced Constipation market?
• Who are the Opioid-Induced Constipation manufacturers across the globe?
• Which geographical location is dominant in the Opioid-Induced Constipation market?
• Which are the top industry players in the Opioid-Induced Constipation?
About Us:
The healthcare industry is surely facing disruptions with global economies giving high importance to individual health. In this scenario, we expect our clients to get deep insights to power their innovations in the right direction. We have been keeping a close watch on the changes and modifications happening in the healthcare domain. As per our understanding, these alterations are active and unexampled.
Contact Us:
Healthcare Market Reports
sales@healthcaremarketreports.com
+1(929)-450-2887
